|
SURF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17420000003798E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.87014999999402E-05 |
| Normal-vs-Stage2 |
1.565530E-02 |
| Normal-vs-Stage3 |
3.90090000002008E-06 |
| Normal-vs-Stage4 |
9.989400E-04 |
| Stage1-vs-Stage2 |
8.228000E-01 |
| Stage1-vs-Stage3 |
6.045200E-01 |
| Stage1-vs-Stage4 |
9.808000E-01 |
| Stage2-vs-Stage3 |
5.499400E-01 |
| Stage2-vs-Stage4 |
8.222800E-01 |
| Stage3-vs-Stage4 |
6.974600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.7182999951545E-08 |
| Normal-vs-AfricanAmerican |
4.657200E-01 |
| Normal-vs-Asian |
8.424000E-02 |
| Caucasian-vs-AfricanAmerican |
1.173610E-02 |
| Caucasian-vs-Asian |
8.119200E-01 |
| AfricanAmerican-vs-Asian |
4.112000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.31660000002309E-06 |
| Normal-vs-Female |
1.53307999999353E-05 |
| Male-vs-Female |
5.423000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.540580E-01 |
| Normal-vs-Age(41-60Yrs) |
1.87640000204325E-08 |
| Normal-vs-Age(61-80Yrs) |
2.212400E-04 |
| Normal-vs-Age(81-100Yrs) |
8.699100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.366000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.085600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.291000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.501600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.825000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.313400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.250400E-02 |
| Normal-vs-Grade 2 |
7.246100E-04 |
| Normal-vs-Grade 3 |
2.40029999987179E-07 |
| Normal-vs-Grade 4 |
3.84909999999739E-05 |
| Grade 1-vs-Grade 2 |
9.240400E-01 |
| Grade 1-vs-Grade 3 |
5.886600E-01 |
| Grade 1-vs-Grade 4 |
4.489800E-01 |
| Grade 2-vs-Grade 3 |
3.118800E-01 |
| Grade 2-vs-Grade 4 |
1.826420E-01 |
| Grade 3-vs-Grade 4 |
4.814000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.60049999984058E-07 |
| Normal-vs-ccB subtype |
7.63888952093339E-12 |
| ccA subtype-vs-ccB subtype |
6.442000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.02599999951947E-07 |
| Normal-vs-N1 |
3.762800E-01 |
| N0-vs-N1 |
5.689000E-01 |
|
|
